Bristol Myers sues US government over Medicare drug price negotiation plan
June 16 (Reuters) – Bristol Myers Squibb Co (BMY.N) on Friday sued the U.S. government in an attempt to halt the Medicare drug price negotiation program that analysts believe will … Read More